NPDev Labs

NPDev Trends · What a country is searching for, explained from its coverage

Trending search

ozempic versus retatrutide a1c study

Approximate search volume: 1000+First seen 2026-10-28 12:22 UTCLast seen 2026-10-28 12:52 UTCUnited States

No explainer has been written about this search yet. Explanations are written at most once an hour, and only when a search has new coverage, from the stored headlines below.

Related coverage stored for this search

Headlines and links only, as the publishers' feed carried them. Headline-only coverage: this site has not read any of these articles.

  1. [1]New weight loss drug retatrutide provides double the weight loss of Ozempic, data shows

    ABC News - Breaking News, Latest News and Videos · first seen 2026-10-28 12:22 UTC · last seen 2026-10-28 12:52 UTC

  2. [2]Bye bye Ozempic: Eli Lilly says its new drug retatrutide more than doubles weight loss

    Yahoo · first seen 2026-10-28 12:22 UTC · last seen 2026-10-28 12:52 UTC

  3. [3]Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trial

    Eli Lilly · first seen 2026-10-28 12:22 UTC · last seen 2026-10-28 12:22 UTC

  4. [4]Lilly's next-gen drug outshines Ozempic on weight loss, blood sugar control in trial

    Reuters · first seen 2026-10-28 12:37 UTC · last seen 2026-10-28 12:52 UTC

Feed history for this search

Seen in the feed 3 times between 2026-10-28 12:22 UTC and 2026-10-28 12:52 UTC. Each read is stored with the label and headline count the feed carried then; the search keeps that history here after it stops trending.

  1. 2026-10-28 12:52 UTCpublisher's label 1000+ · 4 related headlines

  2. 2026-10-28 12:37 UTCpublisher's label 1000+ · 4 related headlines · 1 new

  3. 2026-10-28 12:22 UTCpublisher's label 500+ · 3 related headlines · 3 new

Comments and bookmarks

Comments are plain text from NPDev accounts. Bookmarks stay private to the account that saved them.

No comments yet. Be the first to say something.

Sign in to join the conversation.

Also trending